Business
Abbott Laboratories Inc. said Monday that it would acquire Kos Pharmaceuticals Inc. in a $3.7-billion deal that would make it the leader in the hot field of drugs to boost “good” HDL cholesterol.
Nov. 7, 2006
Abbott Laboratories has agreed to sell its branded generic drug business in developed countries to Mylan Inc. in a deal valued at $5.3 billion.
July 14, 2014
Science & Medicine
Genta filed for permission Tuesday to begin testing the first therapeutic drug that incorporates molecules that some scientists say could hold the key to treating diseases now considered incurable.
Aug. 28, 1991
Illinois drug maker AbbVie Inc. said Friday it would buy European rival Shire for $55 billion and reincorporate in Britain, allowing the company to slash its tax rate in the latest move by an American firm to shelter its foreign earnings.
July 18, 2014
When Scripps Research Institute signed a 10-year, $300-million research agreement in December that gives Swiss pharmaceutical giant Sandoz first rights on all technology developed at the La Jolla facility, neither party anticipated the firestorm that was to erupt.
March 22, 1993
Three nationally known brain researchers at UC Irvine who have spent more than two decades studying the origins of memory have formed a private pharmaceutical firm to develop diagnostic products and drugs to help victims of Alzheimer’s disease.
Sept. 9, 1988
A massive pharmaceutical merger that will send the headquarters of a major U.S. drug maker overseas ramps up pressure on Congress to curtail the ability of companies to shelter foreign earnings.
Robert L. McNeil Jr. dies at 94; chemist who promoted Tylenol
May 31, 2010
The head of SmithKline Beckman’s U.S. pharmaceutical division has resigned--a move analysts attributed to the drug maker’s efforts to boost sagging profits.
July 27, 1988
After his family’s drug company was sold to Johnson & Johnson, he became a philanthropist.